Skip to main content
Equibles

BOOTHBAY FUND MANAGEMENT, LLC

Position in AURA — Aura Biosciences, Inc.

CIK 1549230 NEW YORK, NY
Back to AURA Full portfolio

Position in AURA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,435,127
+$6,298,638 QoQ
Shares Held
906,356
+4342.5% QoQ
Ownership
0.874%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#27
of 146 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AURA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $666,641,771 across 159 Biotechnology names. AURA ranks #21 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 465,787 $87,232,589
2 ABVX
Abivax S.A.
 563,367 $75,074,286
3 EXEL
Exelixis, Inc.
 804,095 $43,750,808
4 PCVX
Vaxcyte, Inc.
 534,163 $31,050,895
5 COGT
Cogent Biosciences, Inc.
 692,825 $26,812,327
6 CGEM
Cullinan Therapeutics, Inc.
 1,082,611 $19,714,346
7 TNGX
Tango Therapeutics, Inc.
 500,497 $15,645,536
8 AVTX
Avalo Therapeutics, Inc.
 702,051 $12,973,902

All Filings in AURA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,435,127 906,356
2026-03-31 $136,489 20,402